| +/+ | Unknown | 04 | c.185G>A | - | p.Arg62Gln | - | RPS19_00028 | - | Missense mutation; Leucine not effective in increasing translational efficiency in lymphocytes. | CpG | Impairs ribosomal association but not nucleolar localization | - | Apparently normal protein levels. Intermediate stability (HEK293) [1] | Nucleolar localization, but no ribosome association (HeLa-HEK293) [1]. It alters the ultrastructural nucleolar organization in dermal fibroblasts [2] | 18S rRNA processing defect both in yeast (orthologue mutation: p.Arg63Gln) and in human dermal fibroblasts, as indicated by increase in 21S pre-rRNA [2,3]. Accumulation of 45S and 41S precursors is observed in dermal fibroblasts [2]; yeast cells show nucleolar accumulation of pre-40S particles [3] | Translation rate reduced to 56%  of controls after transfection in K562 cells [4]. In lymphocytes, translation is reduced to 66% of controls in basal conditions and  to 62% after PHA activation [4] | The human mutation impairs growth of skin fibroblasts [2] and the yeast orthologue mutation (p.Arg63Gln) impairs but does not abolish cell growth in yeast [3] | translation was found reduced in lymphocytes from all the DBA subjects studied irrespective of the presence of RPS19 mutations [4] | [1] Angelini et al (2007) Hum Mol Genet 16, 1720-7; [2]Choesmel et al (2007) Blood 109, 1275-83; [3] Léger-Silvestre et al (2005) J Biol Chem 280, 38177-85; [4] Cmejlova et al (2006) Haematologica 91, 1456-64 |